Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Danish (OMX) Biotech Industry Analysis

UpdatedAug 10, 2026
DataAggregated Company Financials
Companies5
  • 7D7.4%
  • 3M10.1%
  • 1Y27.4%
  • YTD-6.4%

In the last week, the Biotech industry is up 7.4%, with Genmab up 8.3%. This takes the industry's 12 month performance to a gain of 27%. As for the next few years, earnings are expected to grow by 4.5% per annum.

Industry Valuation and Performance

Has the Danish Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 10 Aug 2026DKK 156.7bDKK 41.9bDKK 12.6b17x12.4x3.7x
Wed, 08 Jul 2026DKK 152.6bDKK 40.8bDKK 12.9b12.3x11.9x3.7x
Fri, 05 Jun 2026DKK 134.8bDKK 40.3bDKK 12.8b11.9x10.6x3.3x
Sun, 03 May 2026DKK 140.9bDKK 39.2bDKK 13.9b10.5x10.1x3.6x
Tue, 31 Mar 2026DKK 139.7bDKK 39.8bDKK 14.0b10.8x10x3.5x
Thu, 26 Feb 2026DKK 154.0bDKK 39.7bDKK 14.9b6.2x10.3x3.9x
Sat, 24 Jan 2026DKK 177.3bDKK 40.5bDKK 18.9b6.3x9.4x4.4x
Mon, 22 Dec 2025DKK 175.5bDKK 40.6bDKK 19.0b6.1x9.2x4.3x
Wed, 19 Nov 2025DKK 168.0bDKK 40.9bDKK 19.1b5.8x8.8x4.1x
Fri, 17 Oct 2025DKK 185.5bDKK 38.9bDKK 16.8b13.2x11.1x4.8x
Sun, 14 Sep 2025DKK 158.8bDKK 38.8bDKK 16.7b12.7x9.5x4.1x
Tue, 12 Aug 2025DKK 126.0bDKK 29.8bDKK 8.9b11.7x14.2x4.2x
Thu, 10 Jul 2025DKK 124.6bDKK 26.9bDKK 7.3b11x17.1x4.6x
Sat, 07 Jun 2025DKK 137.5bDKK 27.5bDKK 7.5b11.3x18.3x5x
Mon, 05 May 2025DKK 136.0bDKK 27.3bDKK 7.7b11.9x17.7x5x
Wed, 02 Apr 2025DKK 128.5bDKK 27.3bDKK 7.7b11.3x16.7x4.7x
Fri, 28 Feb 2025DKK 165.7bDKK 27.7bDKK 7.8b12.5x21.2x6x
Sun, 26 Jan 2025DKK 166.7bDKK 26.0bDKK 4.7b17.1x35.5x6.4x
Tue, 24 Dec 2024DKK 160.6bDKK 26.0bDKK 4.7b16.6x34.2x6.2x
Thu, 21 Nov 2024DKK 157.9bDKK 26.0bDKK 4.7b16.5x33.5x6.1x
Sat, 19 Oct 2024DKK 174.2bDKK 25.5bDKK 5.5b21x31.8x6.8x
Mon, 16 Sep 2024DKK 199.3bDKK 25.5bDKK 5.5b23.8x36.4x7.8x
Wed, 14 Aug 2024DKK 195.5bDKK 26.0bDKK 5.7b18.2x34.3x7.5x
Fri, 12 Jul 2024DKK 194.6bDKK 24.8bDKK 5.6b17.6x34.6x7.8x
Sun, 09 Jun 2024DKK 179.2bDKK 24.8bDKK 5.6b18.5x31.8x7.2x
Tue, 07 May 2024DKK 181.6bDKK 25.2bDKK 6.2b16.1x29.5x7.2x
Thu, 04 Apr 2024DKK 186.7bDKK 23.9bDKK 5.0b19.6x37.1x7.8x
Sat, 02 Mar 2024DKK 184.8bDKK 22.8bDKK 4.3b23.5x43.2x8.1x
Mon, 29 Jan 2024DKK 167.0bDKK 23.3bDKK 4.2b22.9x40.1x7.2x
Wed, 27 Dec 2023DKK 175.3bDKK 23.3bDKK 4.2b25.7x42.1x7.5x
Fri, 24 Nov 2023DKK 171.6bDKK 23.3bDKK 4.2b24.5x41.2x7.4x
Sun, 22 Oct 2023DKK 162.9bDKK 22.0bDKK 4.7b18.9x34.4x7.4x
Tue, 19 Sep 2023DKK 199.5bDKK 22.0bDKK 4.7b23.1x42.1x9.1x
Thu, 17 Aug 2023DKK 190.1bDKK 20.6bDKK 3.9b36.5x49.1x9.2x
Price to Earnings Ratio

49.1x


Total Market Cap: DKK 190.1bTotal Earnings: DKK 3.9bTotal Revenue: DKK 20.6bTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Biotech Industry Price to Earnings3Y Average 24.9x202420252026
Current Industry PE
  • Investors are pessimistic on the Danish Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 12.4x which is lower than its 3-year average PE of 24.9x.
  • The 3-year average PS ratio of 5.9x is higher than the industry's current PS ratio of 3.7x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have grown 48% per year over the last three years.
  • Revenues for these companies have grown 27% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Danish Healthcare industry?

DK Market0.73%
Healthcare1.43%
Biotech7.37%
Biotech7.37%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
GMAB GenmabDKK 1.99k7.9%
+DKK 5.6b		46.7%PE23.3x
ZEAL Zealand PharmaDKK 326.306.4%
+DKK 1.4b		-1.1%PE3.6x
STRAP Strategic PartnersDKK 700.002.2%
+DKK 625.7k		-33.6%PE21.7x

Latest News

GMAB
DKK 1,992.00
Genmab
7D
7.9%
1Y
46.7%
Analysis Article • Aug 09

Genmab A/S Just Beat EPS By 29%: Here's What Analysts Think Will Happen Next

It's been a good week for Genmab A/S ( CPH:GMAB ) shareholders, because the company has just released its latest...
BAVA
DKK 176.30
Bavarian Nordic
7D
-1.9%
1Y
-25.7%
ZEAL
DKK 326.30
Zealand Pharma
7D
6.4%
1Y
-1.1%
Narrative Update • Jul 23

ZEAL: Future Returns Will Hinge On Obesity Pipeline Execution Timing

The updated analyst price target for Zealand Pharma moves to DKK 300 from DKK 400. This reflects a more cautious stance as analysts point to fewer near term catalysts, lower peak sales expectations for petrelintide and survodutide, and a higher assumed discount rate and future P/E in their models.
BIOPOR
DKK 1.15
BioPorto
7D
-3.4%
1Y
-10.7%
STRAP
DKK 700.00
Strategic Partners
7D
2.2%
1Y
-33.6%